Germany’s Biotech Boom
The coronavirus pandemic has given German biotechnology companies a massive boom. What does the state of the industry look like two years after the start of the crisis?
Your company is already operating in Germany and you would now like to export worldwide?
The coronavirus pandemic has given German biotechnology companies a massive boom. What does the state of the industry look like two years after the start of the crisis?
Germany's biotech firms are booming, innovations are being made using 3D printing and digital apps are an export hit in the thriving life sciences sector.
Strong demand for coronavirus vaccines is driving sales and production growth in Germany’s pharmaceutical industry.
Start-ups and scale-ups from Germany are constantly in the headlines. Sometimes the efforts of smaller start-ups go unnoticed. Here we showcase selected start-up developments worthy of attention.
The life sciences sector is carrying out mRNA-based research to develop vaccines for cancer, novel gene and cell therapies to treat Parkinson's, and providing a home for global pandemic research.
Germany’s biotech sector is playing an important role in combating Covid-19. The sector is booming, with major investment bringing increased confidence to an in-demand market.
The role of biotech companies in the pandemic has highlighted the importance of the medical biotechnology industry and promoted investment in this sector.
Germany's life sciences market continues to attract international investors in sectors ranging from coronavirus vaccine production to medical cannabis products.